Who Should Undergo Chronic Total Occlusions Percutaneous Coronary Intervention and When?: An Evidence-Based Approach to the Patient Referred for Percutaneous Coronary Intervention of Chronic Total Occlusion.
Kevin SorianoGinger Y JiangLauren BalkanHector TamezRobert W YehPublished in: The American journal of cardiology (2024)
Chronic total occlusions (CTO) of the coronary arteries are common among patients presenting to the cardiac catheterization laboratory, and data suggests a worse overall prognosis in patients with CTOs. Percutaneous coronary intervention (PCI) of CTOs has been shown to improve anginal symptoms in observational studies and in a limited number of randomized trials. However, CTO PCI has not been shown to lead to a reduction in other important end points such as myocardial infarction or death. Furthermore, despite recent advances in the field, CTO PCI still carries higher risks and a lower likelihood of success compared with non-CTO PCI. Thus, determining which patients may be appropriate for CTO PCI is challenging and must involve a comprehensive risk-benefit analysis and discussion with the patient. Therefore, we review the currently available data regarding CTO PCI, including the clinical outcomes, the role of preprocedural ischemia testing, and various procedural success and risk stratification scores. Finally, we present our approach to the patient referred for CTO PCI.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- coronary artery bypass grafting
- case report
- atrial fibrillation
- left ventricular
- coronary artery bypass
- end stage renal disease
- electronic health record
- chronic kidney disease
- ejection fraction
- big data
- coronary artery
- machine learning
- data analysis
- depressive symptoms
- blood flow
- human health
- deep learning